Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Field

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|July 27, 2010
Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trialJean-Christophe Mercier, Helmut Hummler, Xavier Durrmeyer, et al.
Pediatrics|October 3, 2007
Characteristics of neonatal units that care for very preterm infants in Europe: results from the MOSAIC studyPatrick Van Reempts, Ludwig Gortner, David Milligan, et al.
Health Technology Assessment (Winchester, England)|February 14, 2018
Computerised interpretation of the fetal heart rate during labour: a randomised controlled trial (INFANT)Peter Brocklehurst, David Field, Keith Greene, et al.
Journal of Perinatal Medicine|September 6, 2020
Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trialAnne Greenough, Fabrice Decobert, David Field, et al.
Science (New York, N.Y.)|November 18, 2017
Evolution of flower color pattern through selection on regulatory small RNAsDesmond Bradley, Ping Xu, Irina-Ioana Mohorianu, et al.
Pediatrics|August 14, 2013
Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infantsXavier Durrmeyer, Helmut Hummler, Manuel Sanchez-Luna, et al.
Diabetes Care|February 22, 2023
Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort StudiesTauseef A Khan, David Field, Victoria Chen, et al.
The New England Journal of Medicine|January 24, 2024
Trial of Selective Early Treatment of Patent Ductus Arteriosus with IbuprofenSamir Gupta, Nimish V Subhedar, Jennifer L Bell, et al.
Eclinicalmedicine|January 16, 2026
Corrigendum to 'Two-year outcomes after selective early treatment of patent ductus arteriosus with ibuprofen in preterm babies: follow-up of Baby-OSCAR-a randomised controlled trial' [eClinicalMedicine, Volume 87, September 2025, 103424]Samir Gupta, Heather O'Connor, Edmund Juszczak, et al.
Eclinicalmedicine|September 2, 2025
Two-year outcomes after selective early treatment of patent ductus arteriosus with ibuprofen in preterm babies: follow-up of Baby-OSCAR-a randomised controlled trialSamir Gupta, Heather O'Connor, Edmund Juszczak, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|July 27, 2010
Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trialJean-Christophe Mercier, Helmut Hummler, Xavier Durrmeyer, et al.
Pediatrics|October 3, 2007
Characteristics of neonatal units that care for very preterm infants in Europe: results from the MOSAIC studyPatrick Van Reempts, Ludwig Gortner, David Milligan, et al.
Health Technology Assessment (Winchester, England)|February 14, 2018
Computerised interpretation of the fetal heart rate during labour: a randomised controlled trial (INFANT)Peter Brocklehurst, David Field, Keith Greene, et al.
Journal of Perinatal Medicine|September 6, 2020
Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trialAnne Greenough, Fabrice Decobert, David Field, et al.
Science (New York, N.Y.)|November 18, 2017
Evolution of flower color pattern through selection on regulatory small RNAsDesmond Bradley, Ping Xu, Irina-Ioana Mohorianu, et al.
Pediatrics|August 14, 2013
Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infantsXavier Durrmeyer, Helmut Hummler, Manuel Sanchez-Luna, et al.
Diabetes Care|February 22, 2023
Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort StudiesTauseef A Khan, David Field, Victoria Chen, et al.
The New England Journal of Medicine|January 24, 2024
Trial of Selective Early Treatment of Patent Ductus Arteriosus with IbuprofenSamir Gupta, Nimish V Subhedar, Jennifer L Bell, et al.
Eclinicalmedicine|January 16, 2026
Corrigendum to 'Two-year outcomes after selective early treatment of patent ductus arteriosus with ibuprofen in preterm babies: follow-up of Baby-OSCAR-a randomised controlled trial' [eClinicalMedicine, Volume 87, September 2025, 103424]Samir Gupta, Heather O'Connor, Edmund Juszczak, et al.
Eclinicalmedicine|September 2, 2025
Two-year outcomes after selective early treatment of patent ductus arteriosus with ibuprofen in preterm babies: follow-up of Baby-OSCAR-a randomised controlled trialSamir Gupta, Heather O'Connor, Edmund Juszczak, et al.
Pageof 10